The growth hormone (GH)–insulin-like growth factor (IGF)-I axis is a key endocrine
mechanism regulating linear growth in children. While paediatricians have a good …

The terms 'idiopathic short stature'(ISS) and 'small for gestational age'(SGA) were first used
in the 1970s and 1980s. ISS described non-syndromic short children with undefined …

Background While several studies have been published so far on the effect of COVID-19
pandemic on health care for non-COVID-19 diseases, to date no study evaluated the impact …

Short stature is a common reason for referral to pediatric endocrinologists. Multiple factors,
including genetic, prenatal, postnatal, and local environmental factors, can impair growth …

The “360° GH in Europe” meeting, which examined various aspects of GH diseases, was
held in Lisbon, Portugal, in June 2016. The Merck KGaA (Germany) funded meeting …

Digitalization of healthcare delivery is rapidly fostering development of precision medicine.
Multiple digital technologies, known as telehealth or eHealth tools, are guiding …

Determining the pathogenesis of pediatric growth disorders is often challenging. In many
cases, no pathogenesis is identified, and a designation of idiopathic short stature is used …

Paediatric disorders of impaired linear growth are challenging to manage, in part because of
delays in the identification of pathological short stature and subsequent referral and …

Objectives The widespread variation seen in human growth globally stands at odds with the
global health perspective that young child growth should not vary across populations if …

Background In low-and middle-income countries, poverty and impaired growth prevent
children from meeting their cognitive developmental potential. There are few studies …